Literature DB >> 14984152

Progression of osteoarthritis following TPLO surgery: a prospective radiographic study of 40 dogs.

R M Rayward1, D G Thomson, J V Davies, J F Innes, R G Whitelock.   

Abstract

The aim of this prospective study was to assess the progression of osteoarthritis following tibial plateau levelling osteotomy (TPLO) surgery. Osteoarthritis was monitored radiographically by means of an osteophyte scale on entry to the study, and at six weeks and six months following surgical intervention. Forty dogs were recruited to the study. At each visit, animals were assessed clinically, radiographically, by force platform analysis and by synovial fluid sampling. The radiographic data is the subject of this report. A significant increase in mean osteophyte score was noted between the entry and six-month examination time point. This increase in the mean osteophyte score was due to the increased score recorded in 16 dogs. However, in the majority of dogs, there was no progression of osteophytosis during the course of this study.

Entities:  

Mesh:

Year:  2004        PMID: 14984152     DOI: 10.1111/j.1748-5827.2004.tb00209.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  9 in total

1.  Radiographic and functional evaluation of dogs at least 1 year after tibial plateau leveling osteotomy.

Authors:  Devon J Boyd; Craig W Miller; Sheila M Etue; Gabrielle Monteith
Journal:  Can Vet J       Date:  2007-04       Impact factor: 1.008

2.  In vitro 3-dimensional kinematic evaluation of 2 corrective operations for cranial cruciate ligament-deficient stifle.

Authors:  Nadège Chailleux; Bertrand Lussier; Jacques De Guise; Yan Chevalier; Nicola Hagemeister
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

3.  Clinical assessment following tibial tuberosity advancement in 28 stifles at 6 months and 1 year after surgery.

Authors:  Tamara L MacDonald; David A Allen; Gabrielle J Monteith
Journal:  Can Vet J       Date:  2013-03       Impact factor: 1.008

4.  Locking compression plates versus locking plates for tibial plateau levelling osteotomy in dogs: progression of osteoarthritis, bone healing score and lameness degree.

Authors:  Francesco Macrì; Luca Cicero; Vito Angileri; Vito Biondi; Piero Miele; Lorenzo Scaletta; Giovanna Lucrezia Costa; Giovanni Cassata; Simona Di Pietro
Journal:  BMC Vet Res       Date:  2021-05-13       Impact factor: 2.741

5.  Partial Cranial Cruciate Ligament Tears Treated with Stem Cell and Platelet-Rich Plasma Combination Therapy in 36 Dogs: A Retrospective Study.

Authors:  Sherman O Canapp; Christopher S Leasure; Catherine Cox; Victor Ibrahim; Brittany J Carr
Journal:  Front Vet Sci       Date:  2016-12-14

6.  Long-term outcome and progression of osteoarthritis in uncomplicated cases of cranial cruciate ligament rupture treated by tibial plateau leveling osteotomy in dogs.

Authors:  Masakazu Shimada; Nichika Mizokami; Tom Ichinohe; Nobuo Kanno; Shuji Suzuki; Takuya Yogo; Yasuji Harada; Yasushi Hara
Journal:  J Vet Med Sci       Date:  2020-05-25       Impact factor: 1.267

7.  Bayesian and Machine Learning Models for Genomic Prediction of Anterior Cruciate Ligament Rupture in the Canine Model.

Authors:  Lauren A Baker; Mehdi Momen; Kore Chan; Nathan Bollig; Fernando Brito Lopes; Guilherme J M Rosa; Rory J Todhunter; Emily E Binversie; Susannah J Sample; Peter Muir
Journal:  G3 (Bethesda)       Date:  2020-08-05       Impact factor: 3.154

8.  Inflammatory pattern of the infrapatellar fat pad in dogs with canine cruciate ligament disease.

Authors:  Manuel R Schmidli; Bettina Fuhrer; Nadine Kurt; David Senn; Michaela Drögemüller; Ulrich Rytz; David E Spreng; Simone Forterre
Journal:  BMC Vet Res       Date:  2018-05-16       Impact factor: 2.741

9.  Relationship between the stage of osteoarthritis before and six months after tibial tuberosity advancement procedure in dogs.

Authors:  Stefania Pinna; Francesco Lanzi; Alessia Cordella; Alessia Diana
Journal:  PLoS One       Date:  2019-08-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.